Samuel Legeay
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Health, Toxicology and Mutagenesis top 10%
- Biochemistry top 10%
- Physiology
- Co-authors
- Sébastien FaureNicolas ClereMarion RodierEmilie RogerBruno LapiedVéronique Apaire-MarchaisPatrick SaulnierFrédéric Lagarce
- Topics
- Nanoparticle-Based Drug Delivery (6 papers)Protein Interaction Studies and Fluorescence Analysis (4 papers)Lipid Membrane Structure and Behavior (4 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Samuel Legeay
26 papers receiving 665 citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 164
- Pathology and Forensic Medicine 124
- Health, Toxicology and Mutagenesis 109
- Biochemistry 72
- Physiology 69
Countries citing papers authored by Samuel Legeay
This map shows the geographic impact of Samuel Legeay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Legeay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Legeay more than expected).
Fields of papers citing papers by Samuel Legeay
This network shows the impact of papers produced by Samuel Legeay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Legeay. The network helps show where Samuel Legeay may publish in the future.
Co-authorship network of co-authors of Samuel Legeay
This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Legeay. A scholar is included among the top collaborators of Samuel Legeay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Legeay. Samuel Legeay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 16 | |
| 7 | 41 | |
| 8 | 0 | |
| 9 | 7 | |
| 10 | 8 | |
| 11 | 16 | |
| 12 | 6 | |
| 13 | 3 | |
| 14 | 18 | |
| 15 | 4 | |
| 16 | 5 | |
| 17 | 1 | |
| 18 | 99 | |
| 19 | 25 | |
| 20 | 267 |
About Samuel Legeay
Samuel Legeay is a scholar working on Biomaterials, Pharmacology and Biochemistry, having authored 31 papers that have together received 682 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Protein Interaction Studies and Fluorescence Analysis (4 papers) and Lipid Membrane Structure and Behavior (4 papers). The work is most often cited by research in Biochemistry (72 citations), Health, Toxicology and Mutagenesis (109 citations) and Pathology and Forensic Medicine (124 citations). Samuel Legeay has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Sébastien Faure, Nicolas Clere, Marion Rodier, Emilie Roger, Bruno Lapied, Véronique Apaire-Marchais, Patrick Saulnier, Frédéric Lagarce, Jérôme Bejaud and Grégory Hilairet. Their work appears in journals such as Macromolecules, Scientific Reports and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.